EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vivo immunomodulatory effect and safety of MSC-derived secretome

Dwi Aris Agung Nugrahaningsih, Purwadi Purwadi, Is Sarifin, Indra Bachtiar, Sunarto Sunarto, Ubaidillah Ubaidillah, Ines Larasati, Pamungkas Bagus Satriyo, Dicka Wahyu Setiasari, Maria Nur Hasanah, Jarir At-thobari, Sofia Mubarika

F1000Research · 07.10.2024 · 12 · 421

DOI: 10.12688/f1000research.131487.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 07.10.2024. Verfasst von Dwi Aris Agung Nugrahaningsih und 11 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kepolisian Negara Republik Indonesia..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Secretomes have been gaining interest in treating several diseases due to their pharmaceutical effects, such as the immunomodulatory effect. This study aimed to determine the immunomodulatory effect of secretomes derived from human umbilical cord mesenchymal stem cells (MSCs) and their safety.

Methods

We conducted an in vivo immunomodulatory study using a carbon clearance assay. The safety of single-dose administration of secretome was done using fixed-dose methods of acute toxicity test.

Results

The phagocytic index was higher in mice treated with secretome than in untreated mice. The acute toxicity study also showed that the administration of secretome derived from human umbilical cord MSCs did not change the mice’s body weight, physical examination results, organ weight, and gross anatomy examination.

Conclusions

This study presents the potential of secretome derived from MSCs as a safe immunomodulatory agent.

Förderung

  • Kepolisian Negara Republik Indonesia.

Zitieren

APA

Nugrahaningsih, D. A. A., Purwadi, P., Sarifin, I., Bachtiar, I., Sunarto, S., Ubaidillah, U., Larasati, I., Satriyo, P. B., Setiasari, D. W., Hasanah, M. N., At-thobari, J., & Mubarika, S. (2024). In vivo immunomodulatory effect and safety of MSC-derived secretome. F1000Research, 12, 421. https://doi.org/10.12688/f1000research.131487.2

Vancouver

Nugrahaningsih DAA, Purwadi P, Sarifin I, Bachtiar I, Sunarto S, Ubaidillah U, et al. In vivo immunomodulatory effect and safety of MSC-derived secretome. F1000Research. 2024;12:421. doi:10.12688/f1000research.131487.2

BibTeX
@article{Nugrahaningsih2024,
  author = {Nugrahaningsih, Dwi Aris Agung and Purwadi, Purwadi and Sarifin, Is and Bachtiar, Indra and Sunarto, Sunarto and Ubaidillah, Ubaidillah and Larasati, Ines and Satriyo, Pamungkas Bagus and Setiasari, Dicka Wahyu and Hasanah, Maria Nur and At-thobari, Jarir and Mubarika, Sofia},
  title = {In vivo immunomodulatory effect and safety of MSC-derived secretome},
  journal = {F1000Research},
  year = {2024},
  volume = {12},
  pages = {421},
  doi = {10.12688/f1000research.131487.2}
}
Kostenlos starten →